Establishment of an HLA-typed cohort of 1000 healthy blood donors and use of a dendritic cell priming assay to prime naive T cells to structurally divergent drugs

Ítems similars

• HLA-DQ restricted activation of nitroso-sulfamethoxazole-specific CD4+ T-lymphocytes
  per: Ogese, Monday, et al.
  Publicat: (2014)
• Drug Induced Hypersensitivity and the HLA Complex
  per: Alfirevic, Ana, et al.
  Publicat: (2010)
• Identification of susceptible HLA class II co-amoxiclav genotypes based on the analysis of drug-specific T-cells from patients with liver injury
  per: Saide, Katy, et al.
  Publicat: (2014)
• Skewing of the TCR V repertoire in SMX-NO specific T cell responses
  per: Faulkner, Lee, et al.
  Publicat: (2014)
• The effect of inhibitory signals on the priming of drug-hapten-specific T-cells that express distinct Vβ receptors
  per: Gibson, Andrew, et al.
  Publicat: (2017)